chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a licensed practical nurse (L.P.N.) concerning a healthy 11-year-old female who is not on any medication, who on an unspecified date at 2:00 pm was vaccinated with the first dose of Gardasil. Concomitant therapy included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid, VAQTA and MENJUGATE. Subsequently, following vaccination, the patient experienced dizziness. No other symptoms were reported. It was reported that the patient did not have anything to eat since late in the morning. It is reported that the patient recovered before she left the office. Additional information has been requested.
Pt received Vaxelis and Hib vaccine on same day, No treatment, no adverse reactions noted.
Presented w/fever, cough, and congestion x2 days; dx w/ COVID-19 pna; tx w/abx, zinc, Vit C, steroids; did not require O2. dc'd home.
other zoster-related conditions; shingles; Information was received from a lawyer concerning a case in litigation and refers to a patient of unknown age and gender. The patien's concurrent conditions, historical conditions and concurrent conditions were not reported. On or about April of 2012, patient was inoculated with zoster vaccine live (ZOSTAVAX), as prescribed and/or administered by a healthcare provider at health center for the long-term prevention of shingles and zoster-related conditions. Subsequent to patient's zoster vaccine live. As a direct and proximate result of patien's use of zoster vaccine live (ZOSTAVAX) vaccine, patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the events was reported as not recovered. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
Severe chills, restlessness, fever to 102.1.  Also with general malaise for more than 12 hours after onset of symptoms.  Treated symptoms with Advil, rest and fluids by mouth.  Unable to go to work the next day due to inability to sleep.
I received both doses of the Pfizer vaccine in March 2021. I just tested positive for Covid-19. The vaccine does not work.; I received both doses of the Pfizer vaccine in March 2021. I just tested positive for Covid-19.; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: Unknown) via an unspecified route of administration on an unknown date in Mar2021 as dose 2 single and first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: Unknown) via an unspecified route of administration on an unknown date in Mar2021 as dose 1 unknown both for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received both doses of the Pfizer vaccine in Mar2021 and tested positive for COVID-19 on 02Jul2021. The vaccine did not work. The patient underwent lab tests and procedures which included COVID-19 test: positive on 02Jul2021. Outcome of the event was unknown.  Information about lot/batch number has been requested.
Tested positive for Covid-19; Tested positive for Covid-19; Tested positive for flu; This is a spontaneous report from a contactable physician. A 5-decade-old (in her mid-40s) female patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration in Aug2021 (the end of Aug2021) (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced tested positive for covid-19 (covid-19) (medically significant) in 2021 with outcome of unknown, tested positive for covid-19 (drug ineffective) (medically significant) in 2021 with outcome of unknown, tested positive for flu (non-serious) in 2021 with outcome of unknown, shortness of breath (non-serious) in 2021 with outcome of not recovered, severe cough (non-serious) in 2021 with outcome of not recovered. Clinical course reported patient received the 1st dose of Comirnaty during the end of Aug2021 then tested positive for flu and Covid-19. Patient is still experiencing shortness of breath and severe cough. Reporter added that it's been 6 weeks since she received her 1st dose.   The lot number for BNT162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on limited information in the case , a possible causal association between the reported events COVID 19 , Drug ineffective, flu and the suspect drug BNT162B2 cannot be excluded
Left upper outer arm where Varivax given became red, itchy, swollen, and warm to touch 1/29/08 in afternoon-Area of redness was 2 1/2-3 in diameter. Seen in our office 1/29 pm- Dr dx as cellulitis- prescribed Keflex 500 mg tid x 5 days.
Anaphylaxis shock- patient became hypoxic with shortness of breath, chills and tachycardia. EpiPen was administered and 911 was called. Patient was transported to ER.
Red, firm lump at injection site with itching and pain.  First presented about 36 hours following injection.  Lasted about 3 days, with mild itching forabout 3 days.   All symptoms returned on day 7 after injection  with larger diameter red, sore and swollen lump.  Significant pain at the site and in shoulder and intense itching.  Noticed lymph nodes in armpit of the injected arm were sore on days 7 and 8.  Feelings of agitation primarily due to itching.  Also notice a couple of small raised pustules around injection site.  I am currently on day 8 so cannot report on the outcome of this event.
three hours after vaccine, got pain in right upper quadrant-excruciating for over 5 hours, low grade fever, weakness, fatigue and chest heaviness/pain between shoulder blades. did not get out of bed until Saturday 2/13/2021.  I was in bed until Saturday due to being unable to stand or move without assistance of spouse. Sunday was first day out of house and had to take nap due to weakness/fatigue.  Fever lasted until Saturday 2/13/2021. I continue to have fatigue and chest heaviness/heaviness between shoulder blades. left arm pain started within 24 hours, with redness/warmth at site of vaccine
P/inject, arm got immediately numb, felt like throat was closing up & could not breathe; Pt was taken to ER; Dx Anaphylaxis;
p/vax pt exp a varicella like rash consisting of more than 50 lesions w/a mild fever;
Patient is a 44 y.o. male who was in his usual state of health. 3 weeks ago he received flu vaccine. For the days after the flu vaccine his feet felt cold. This resolved. His feet and legs began feeling numb. His hands began feeling numb about a week after the flu vaccine. Wife reports he had some flu-like symptoms, patient states he did not. He does admit to having some upper respiratory infections. One week ago the patient presented to the emergency room with left-sided facial drooping. He was diagnosed with Bell's palsy. He was given prednisone and VALTREX without relief. He's had tingling and numbness in his hands and legs since that time. Leg numbness has progressed and is worsening. He does not have leg weakness. His right leg went out from under him and he twisted his right ankle quite severely. He did not experience as much pain as he would've expected for that degree of injury. He's had some sluggishness to his bowels but no other bladder or bowel symptoms. He has not had chest pain or heaviness but the tingling is coming up to his chest. He denies shortness of breath or difficulty getting a deep breath. High probability Guillain-Barré syndrome given the symptoms. I spoke to neurology on the phone. Spinal tap was recommended. We'll proceed with spinal tap and including IgG index. We'll get MRI brain as demyelinating central process is also a possibility though less likely. Admitted to the hospital to evaluate for negative history for's. Consider EMG. IMAGING: Xr Ankle 3 Or More Vw Right. Result Date: 12/11/2017 NO ACUTE OSSEOUS ABNORMALITY. Electronically signed on 12/11/2017 7:40 PM by MD. Xr Foot 3 Or More Vw Right Result Date: 12/11/2017 NO ACUTE OSSEOUS ABNORMALITY. Electronically signed on 12/11/2017 7:40 PM MD. MRI Brain Without Contrast Result Date: 12/12/2017 NO ACUTE INTRACRANIAL FINDINGS. MILD PARANASAL SINUS DISEASE. Electronically signed on 12/12/2017 3:18 PM by MD. Fl Lumbar Puncture W Opening Pressures And CSF Result Date: 12/12/2017 TECHNICALLY SUCCESSFUL LUMBAR PUNCTURE UNDER FLUOROSCOPIC GUIDANCE. FINAL PATHOLOGY RESULTS ARE PENDING. Electronically signed on 12/12/2017 4:32 PM by MD. HOSPITAL COURSE: This is a 44-year-old male that was admitted for ascending weakness with numbness and tingling in the perineal area and legs. He was found to have elevated protein on LP and was treated with IVIG. Patient did get 5 doses of IVIG. He is mostly independent but still requiring walker to ambulate. Still having some issues with bowel movements and is getting good bowel health for this. Patient will continue with his same medications prescribed as well as starting some SENEKOT at home to try to improve his bowel function I did get home health involved to check on them for a couple of days to ensure that he continues to get better make sure that his bowels continue to get better. He will also be referred to right physical therapy by his outpatient doctor once he feels safe to continue.
This spontaneous prospective pregnancy report was received from a physician assistant and was referring to a 14 years old female patient which had her last menstrual period (LMP) on an unspecified date in June 2015. The patient's concurrent conditions and medical history were not reported. On 09-SEP-2015, the patient was vaccinated with her first dose of GARDASIL 9 which had a lot # of L011846 (dose, route, anatomical place of vaccination and expiration date were not provided). Other suspect therapies included MENACTRA, which were administered on the same date. Information regarding concomitant therapies were not reported. The reporter also stated that at the moment of the vaccination, she asked to the patient if she could be pregnant and the patient denied it. On 22-SEP-2015, the patient returned to the office for amenorrhea and was scheduled for an unspecified blood work and an ultrasound but her mother never took her. On 17-FEB-2016, the patient went to the office for a sick visit (malaise). As she was visibly pregnant the patient was sent directly to the emergency room. Nevertheless, the patient's family continued denying the pregnancy as a possibility. Finally, the reporter stated that the patient was due to deliver any day. At the time of reporting, the outcome of the malaise was unknown. The reporter did not provide a causality assessment between GARDASIL 9 and the event. Additional information has been requested.
The patient was administered 0.3ml of pure, undiluted, Pfizer COVID-19 vaccine around 9:15 AM. When the error was discovered the patient/patient's parents were reached out to. Around 5:30 PM, we finally got in touch with the patient's mother to inform her of the error. At this time the patient's only side effect was a sore arm. We asked the patient's mother to keep us informed of any other side effects/adverse events that occur and have yet to hear anything.
Severe body aches, headache, chills, nausea, sleepiness,  fatigue, swollen lymph nodes - these all started on 4/15/2021 and lasted up until 4/16/2021.  My body is still aches & my lymph nodes are still swollen/ hurt today 4/17/2021. I have taken Tylenol to help w/ the aches & pain.
Patient had vasovagal syncope starting about 5 minutes after vaccination that resolved within 10 minutes. She stayed in pharmacy area for an additional 15 minutes for monitoring
Patient in clinic today for flu vaccination only. Noticed after the patient was dismissed that High Dose Quadrivalent Flu zone 0.7 ml influenza vaccine was mistakenly administered to patient. Parent notified by nursing after consulting with immunization medical director to inform of the incident and potential localized side effects (transient fever, large local reaction). Parent denies patient having any adverse side effect currently. Parent advised to notify primary provider or immunization coordinator with any side effects, and those lasting more than 1-2 days or other concerns. Parent verbalized understanding of/agreement with plan.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 19-FEB-2015, the patient was vaccinated with improperly stored MMR II lot # K008814 and 19-JUN-2016 (unknown strength and route). Concomitant medications were not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Fever; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 21Feb2021 (Sunday) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 25Feb2021, the patient experienced fever and number of other symptoms. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
2 welts 30 hours after the injection. One on the neck and one on the knee.   Two vesicles with severe itching and burning on the left breast 48 hours after the injection.  The vesicles persisted for 2 weeks. Redness in the area persisted for 6 weeks. I took one Benadryl 25 mg after the welts appeared. They subsided overnight.  I took valtrex 500 mg twice a day for 5 days after the vesicles appeared. No objective change in the vesicles occurred
Initial unsolicited report received from a consumer via social media on 10 Oct 2016. This case is linked to 2016SA188144, 2016SA188556, 2016SA188803, 2016SA188804, 2016SA188805, 2016SA188806, 2016SA188807, 2016SA188808, 2016SA188809, 2016SA188810, 2016SA188811, 2016SA188812, 2016SA188813, 2016SA188814, 2016SA188815, 2016SA188816, 2016SA188817, 2016SA188818, 2016SA188819, 2016SA188820, 2016SA188821, 2016SA188822, 2016SA188833, 2016SA188835, 2016SA188836, 2016SA188837, 2016SA188838, 2016SA188839, 2016SA188840, 2016SA188841, 2016SA188842, 2016SA188843, 2016SA188844, 2016SA188845, 2016SA188846, 2016SA188847, 2016SA188848, 2016SA188849, 2016SA188850, 2016SA188851 (Same reporter source, same vaccine). This case involves a male patient (age not reported) who was vaccinated with a dose of Flu shot and pneumonia shot (batch number, expiry date, dose, dose in series, route and site of administration were not reported for both vaccines) on unspecified date. The patient's medical history and concomitant medications were not reported. On an unknown date, following the vaccination, the patient experienced flu and pneumonia. The patient's laboratory data and corrective treatment was not reported. The outcome of events was not reported. Upon medical review, the case was considered as serious due to important medical event: pneumonia. List of documents held by sender: none. Sender's Comments: This is poorly documented case as patient take flu and pneumonia shot every year and had flu and pneumonia. Time to onset is unknown, additional information regarding patient medical history, immune status, past vaccination history and its tolerance are needed to further assess the case. As lab data and culture report are needed to further assess vaccine efficacy. Based on available information the role of vaccine cannot be assessed.
ED to hospital admission for hyponatremia. Patient was admitted to medical for further medical management on the medical floor patient was fluid restricted also home hydrochlorothiazide was discontinued.  Patient sodium responded very slowly nephrology was consulted and her antihypertensive medication was switched to lisinopril.  Calcium channel blockers have been noted to cause bilateral lower extremity swelling in this patient.  Was subsequently give sodium tabs 2 g.  Her sodium increased slowly patient remained neurologically intact no compromise noted she will follow-up with her primary care physician in 1 week to have a repeat BMP. Primary care to ED visit 3 days later and ED adjusted her medications. ED visits and hospital admission within 6 weeks of receiving the COVID vaccine.
Father reported at visit on 7/30/2014 that child had fever of 103 and a seizure three days after vaccines given on 06/30/2014. Child was taken to ER. Father states son did not have any other symptoms prior to the onset of the fever/seizure.
pain at injection site; left hand swelling; left hand numbness; difficulty sleeping; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 68-year-old female patient who received Herpes zoster (Shingrix) (batch number 2YN4S, expiry date 9th July 2021) for prophylaxis.   On 29th March 2019, the patient received the 1st dose of Shingrix (intramuscular). On 29th March 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, hand swelling, numbness in hand and difficulty sleeping. On an unknown date, the outcome of the injection site pain, hand swelling, numbness in hand and difficulty sleeping were recovering/resolving.   It was unknown if the reporter considered the injection site pain, hand swelling, numbness in hand and difficulty sleeping to be related to Shingrix.  Additional case details were reported as follows: The reporter stated that the patient experienced injection site pain, hand swelling, numbness in hand and difficulty sleeping after vaccination and was seen by her physician, and was referred to a neurologist. The reporter consented to follow up.
Immediately after the MMR was given the pt developed a 3x4cm area of pink, blanching rash with central raised urticarial lesions observed for 10 minutes. The area of pink rash decreased. No other rash lesions noted. Instructed to use cool compress, and Benadryl as needed. Return to clinic if symptoms worsen.
Pt received both doses of the Pfizer COVID-19 vaccine, on 2/2/2021 and 2/23/2021.  Pt then developed fatigue and sore throat, was tested by PCP for COVID-19 via PCR on 3/3 and was positive.  Pt was given Bamlanivimab on 3/4 due to risk factors for severe COVID, but symptoms did not worsen and pt was never hospitalized.
Information has been reported in a CDC slide. This spontaneous retrospective pregnancy report as received from a registered nurse (RN) in Centers for Disease Control and Prevention (CDC) concerning a female patient of unknown age, 2 of the two patients who experienced spontaneous abortion. On an unknown date, the patient became pregnant. The last menstrual period (LMP) and estimated date of delivery (EDD) was not known. On an unknown date the patient was administered with a dose of PNEUMOVAX 23 (lot#, dose and route were unspecified) during pregnancy. On an unknown date the patient experienced spontaneous abortion. The outcome of spontaneous abortion was unknown. Upon internal review, spontaneous abortion was considered as other medical significant event. This is one of the 18 reports (PNEUMOVAX 23 administered during pregnancy) that received from the same source. Additional information has been requested.
swollen lymph nodes; tiredness; diarrhea; This is a spontaneous report from a contactable consumer (patient herself). A 60-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in left arm on 10Feb2021 09:15 at single dose for COVID-19 immunisation in workplace clinic. The patient's medical history included AFib, hypertension, known allergies: TB test (allergies to medications, food, or other products: TB test). Concomitant medications included apixaban, digoxin, metoprolol, enalapril; the patient received all the drugs within 2 weeks of vaccination. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL3247), in left arm on 20Jan2021 09:15 AM at single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. On an unspecified date in 2021, the patient experienced swollen lymph nodes, tiredness, diarrhea. The events were considered as non-serious by the consumer. No treatment received for the adverse events. The outcome of the events was recovering.
Starting the Thursday night of the date of administration I started feeling normal side effects reported such as headache, arm pain, and nauesa.  However, starting on the Saturday after administration, my milk supply while breastfeeding my child began to decrease and has continued to do so since then.  Nothing else has changed besides receiving the vaccine.
40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients).    This case was created for 10th out of 40 patients reported. Concomitant medication was not provided. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-698650.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-698650:Master
woke during night with a slight fever (100)  achy joints and  nausea.  got worse as morning wore on.  couldn't eat, but was able to drink fluids.   about 6PM was able to eat yougut.  Temperature was normal.  Slept well that night/   Woke today and  feel ok  able to eat breakfast.
5 minutes post vaccine, developed rash and flushing.  Felt warm.   Pt received benadryl in ER.